These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29466886)

  • 1. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
    Preece RL; Han SYS; Bahn S
    Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Biomarkers in Major Depressive Disorder: An Update.
    Woods AG; Wormwood KL; Iosifescu DV; Murrough J; Darie CC
    Adv Exp Med Biol; 2019; 1140():585-600. PubMed ID: 31347073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
    Ribeiro HC; Zandonadi FDS; Sussulini A
    Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
    Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
    Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
    Hashimoto K
    Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
    MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
    Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
    Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a blood-based diagnostic panel for bipolar disorder.
    Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
    Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.
    Giusti L; Mantua V; Da Valle Y; Ciregia F; Ventroni T; Orsolini G; Donadio E; Giannaccini G; Mauri M; Cassano GB; Lucacchini A
    Mol Biosyst; 2014 Jun; 10(6):1246-54. PubMed ID: 24554194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
    Salvetat N; Checa-Robles FJ; Delacrétaz A; Cayzac C; Dubuc B; Vetter D; Dainat J; Lang JP; Gamma F; Weissmann D
    J Affect Disord; 2024 Jul; 356():385-393. PubMed ID: 38615844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression.
    Kittel-Schneider S; Hahn T; Haenisch F; McNeill R; Reif A; Bahn S
    Front Psychiatry; 2020; 11():189. PubMed ID: 32372978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
    J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics Approach for Biomarker Research in Major Depression: Antidepressant Effects.
    Huang TL; Lo LH
    Curr Drug Metab; 2018; 19(6):502-512. PubMed ID: 29623831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
    Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.